Status:

NOT_YET_RECRUITING

TAG TEAM - Trans Adolescent Group Therapy

Lead Sponsor:

Murdoch Childrens Research Institute

Conditions:

Minority Stress

Acceptability

Eligibility:

All Genders

12-17 years

Phase:

NA

Brief Summary

This project will study the effect of the TAG TEAM group CBT program on the mental health of trans and gender diverse adolescents. TAG TEAM was co-designed by researchers and clinicians with a group o...

Detailed Description

Trans Adolescent Group ThErapy for Alleviating Minority stress (TAG TEAM), is a group Cognitive Behavioural Therapy (CBT) program, originally developed using co-design methodology with trans and gende...

Eligibility Criteria

Inclusion

  • Participants will be enrolled into the RCT only if they meet all the inclusion criteria and none of the exclusion criteria.
  • Identifies as trans, non-binary, or gender diverse
  • Is between the ages of 12 and 17 years inclusive
  • Has completed primary school at the time of enrolment into the study
  • Has current psychological stress symptomology as determined by a score of moderate or above on the DASS-Y
  • Provide informed consent: All participants and parent/legal guardians must be willing to give informed consent

Exclusion

  • Has current acute suicidal symptomology as determined by a combination of clinical judgement and the results of the Ask Suicide-Screening Questions (ASQ) suicide screening tool (e.g., answer yes to question 5) to determine the risk of suicide (has an active plan and/or intent to suicide) at time of screening interview
  • Is actively having treatment with any other group psychological intervention at the time of enrolment into the study
  • Is not proficient in English (as the group Cognitive behaviour therapy (CBT) program will be delivered in English and funds aren't available for interpreters)
  • Previous participation in the feasibility trial
  • Is currently enrolled in tertiary study (e.g., undergraduate university)

Key Trial Info

Start Date :

December 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2026

Estimated Enrollment :

142 Patients enrolled

Trial Details

Trial ID

NCT07151079

Start Date

December 1 2025

End Date

November 1 2026

Last Update

November 21 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Murdoch Children's Research Institute

Parkville, Victoria, Australia, 3052